Ash Paul
@pash22
Public Hlth Dr,interested in evid-based health services commissioning,clinical leadership & hlth policy.My views are my own,RTs are no endorsements
ID: 28824136
04-04-2009 16:39:49
360,360K Tweet
31,31K Followers
34,34K Following
61% voted to downgrade or retire beta-blocker recommendation and 39% to wait for additional evidence from ongoing trials 👇 x.com/kaulcsmc/statu… For deeper dive into current evidentiary support (or lack thereof) 👇 jacc.org/doi/10.1016/j.… JACC Journals John Mandrola, MD Andrew Foy
How much do language models memorize? arxiv.org/abs/2505.24832 via Chawin Sitawarin et al
The Alzheimer’s drug pipeline is healthier than you might think economist.com/science-and-te… via The Economist Robert Howard
Fifth of hospital beds in Welsh Government Health and Social Care occupied by people at end of life nation.cymru/news/fifth-of-… via Nation.Cymru
Callum Williams Ollie Burton Adam Skeen Ellie J Bethany Kelly, DSN, QN @medicalmodelwithabriochebun platinumpizza™ ExplosiveEnema This is a critical question. Explicitly asked posed in Blair's NHS Plan 2000. The bottleneck then was at Senior Reg level. People hung around waiting for consultant jobs until literally someone died. The fear of the profession was the creation of a sub-consultant grade /
🔬 Updated Myeloma Algorithm 2025 for Transplant-Ineligible! [📺VIDEO COMPANION📺] 🥼Vincent Rajkumar at #ASCO25 📊Ideal: Dara-VRd/Isa-VRd 8 cycles, then lenalidomide (std risk) or doublet (high risk). 🎯 Frail: DRd/Isa-Rd 8 cycles, continue 1 drug as tolerated. 🌍 Access-limited: VRd
What's in a Surname? The Effects of Surname Initials on Academic Success aeaweb.org/articles?id=10… via Leeat Yariv et al
One for you RoyalCollegeObsGyn & Ranee Thakar AoMRC . If true, this is shocking GMC !
Ash Paul The Labour Party NHS England The Economist Nope. Buys the whole digital transformation as a way o fixing everything hook, line and sinker (including AI snake oil). It's like they only talked to the planners and not the skeptics...
Cancer patients are dying after choosing fad social media ‘cures’: Oncologists report sufferers are delaying treatment to try unproven diets and essential oils thetimes.com/uk/healthcare/… via Poppy Koronka
Critique of #MAHA Report: Part I open.substack.com/pub/epiellie/p… via Dr Ellie Murray, ScD
Why Surrogate Endpoints Shouldn’t Justify Full Cancer Drug Approvals oncodaily.com/blog/bishal-gy… via Bishal Gyawali, MD, PhD, FASCO